Citation

Szendi G. Neuropsychopharmacol. Hung. 2005; 7(4): e221.

Copyright

(Copyright © 2005, Neuroline - Hungarian Association of Psychopharmacology)

DOI

unavailable

PMID

16496487

Abstract

[Abstract unavailable]

Language: hu

Keywords

Clinical Trials as Topic; Cost of Illness; Drug Approval; Drug Labeling; Humans; Meta-Analysis as Topic; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Suicide; United States; United States Food and Drug Administration